This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The following is a guest article by Dr. Neecey Hudson, PhD – Founder & Chief Scientist at Hood Medicine Initiative. Effective publichealth communication is the cornerstone of any pandemic response. It certainly has potential, if it is pitched to the public in the right way.
It is bittersweet to read the latter half of the title, as our friend and mentor Professor Reinhardt, a health economics pioneer, passed away last year. He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. Two news items illustrate this issue in real time.
The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies. Dell Technologies has developed a suite of digital twin solutions that are specifically designed to accelerate the biotech development process at every stage with patient digital twins.
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Studies Less than 1% of all medical claims include an ICD-10 Z code that documents a social determinant health, according to a data brief from LexisNexis Risk Solutions.
Recent research examining publichealth records in Scotland found that the average lifespan of a person with Type 1 diabetes was 11 years shorter for men and 13 years shorter for women than the average lifespan of those without Type 1 diabetes, according to Medical News Today. According to an article in Glu , 5.3% DKA rate.
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. 2 Digital health is a large (+$900bn by 2032) and growing (13.6%
Note: I may be biased as a University of Michigan graduate of both the School of PublicHealth and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.
The following is a guest article by Bruno Kurtic , Co-Founder, President, and CEO at Bedrock Security It’s becoming increasingly evident that the U.S. The CCP’s national security laws require Chinese firms to share any data requested, which includes the biotech companies that collect, test, and store American genetic data.
She and producer Angel Castillo believe that as treatment devices like pumps become smaller, and insulin pens make injections easier, it all makes daily maintenance more discrete, ultimately allowing a national publichealth problem such as diabetes to remain curtained in misunderstanding. That’s the great irony of it,” Castillo added.
Beth writes that, “a whopping two-thirds of Americans now offer a thumbs-up on pharma” as the title of her article, calling out the 30-point gain from 32% in January 2020 to 62% in February 2021. consumers trusted the biotechhealth industry segment compared with the pharmaceutical segment. Why was this the case?
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content